Research Interests

Open to PhD applications in the field of:

• Stimuli-responsive nanomedicines
• Biologics (RNA and proteins) delivery
• Exosomes and exosome mimetics
• Immunotherapy
• Tumour microenvironment
• Targeted delivery
• Theranostics
• Microfluidics

Make a PhD enquiry

Current Research Opportunities

• Self-Navigating Nanocarriers for Intracellular Protein Delivery

Public outreach & key achievements

• Prostate Cancer Photos competition 2019
• Developing new nanomedicine for advanced prostate cancer
• GSK Emerging Scientist Award for nanomedicine research
• Nanomedicine: promises and challenges for the future of public health

Research students

Name: Ms Raghed Qadadeh
PhD title: RNA lipid nanoparticles targeting tumour microenvironment
Years of Study: 2022-2025
Country: Jordan

Name: Ms Minao Zhang
PhD title: Molecularly imprinted nanoparticles for cancer immunotherapy
Years of Study: 2022-2025
Country: China

Name: Ms Sophie Griffith
PhD title: Designing dually responsive lipid nanoparticles for nucleic acid delivery
Years of Study: 2021-2024
Country: Northern Ireland

Name: Mr Hamoud Alotaibi 
PhD title: Engineering biodegradable nanoparticles for photothermal therapy
Years of Study: 2021-2024
Country: Saudi Arabia

Name: Ms Siyang Wu
PhD title: Developing multifunctional nanocapsules for skin cancer
Years of Study: 2020-2023
Country: China

Name: Ms Ubah Abdi
PhD title: Developing nanomedicines for pancreatic cancer
Years of Study: 2019-2023
Country: UK-Wales

Name: Mr Matt Barker
PhD title: Engineering an ICD stimulated dendritic cell derived exosome-mimetic vaccine against cancer antigens
Years of Study: 2018-2022
Country: UK-England

Alumni: Where are they now

Name: Dr Calvin Cheung
PhD Title: Preparation of multifunctional nanoparticles using microfluidics
Year of Study:  2016-2020
Country: Hong Kong
Current position: Formulation Scientist, Nano and Advanced Materials Institute Limited, Hong Kong

Name: Dr Sara Pereira
PhD title: Developing a thermoresponsive targeted nanomedicine for advanced prostate cancer
Years of Study: 2014-2019 (part-time)
Country: Portugal
Current position: Senior Scientist, AstraZeneca, Cambridge, UK

Name: Dr Vera Silva
PhD title: Development of Novel Cupric- Tirapazamine Liposomes for Hypoxia Selective Therapy
Years of Study: 2014-2017
Country: Portugal
Current position: Oncology Scientist at Engitix Therapeutics, UK

 

 

 

Discover More

• Prostate Cancer Photos competition 2019
  
• Developing new nanomedicine for advanced prostate cancer
  
• GSK Emerging Scientist Award for nanomedicine research
• Nanomedicine: promises and challenges for the future of public health